|
Volumn 8, Issue 10, 2010, Pages 829-845
|
Use of antimalarials in dermatology;Einsatz von antimalariamitteln in der dermatologie
|
Author keywords
chloroquine; hydroxychloroquine; lupus erythematosus; quinacrine
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMINOGLYCOSIDE;
AMMONIUM CHLORIDE;
AMPICILLIN;
AUROTHIOGLUCOSE;
CHLOROQUINE;
CIMETIDINE;
COLESTYRAMINE;
CORTICOSTEROID;
CYCLOSPORIN A;
DIGOXIN;
HYDROXYCHLOROQUINE;
IMIPRAMINE;
KAOLIN;
MEPACRINE;
METHOTREXATE;
NEOSTIGMINE;
PENICILLAMINE;
PHENYLBUTAZONE;
PHYSOSTIGMINE;
PYRIMETHAMINE;
RABIES VACCINE;
RANITIDINE;
RITONAVIR;
TYPHUS VACCINE;
ABDOMINAL CRAMP;
AGRANULOCYTOSIS;
ALLERGIC REACTION;
ALOPECIA;
ANHIDROSIS;
ANTIINFLAMMATORY ACTIVITY;
ANTIMALARIAL ACTIVITY;
ANXIETY;
APLASTIC ANEMIA;
ATOPIC DERMATITIS;
BLOATING;
BLOOD PRESSURE FLUCTUATION;
BLOOD SAMPLING;
BODY WEIGHT;
CLINICAL TRIAL;
CONCENTRATION LOSS;
CONFUSION;
CORNEA DISEASE;
DERMATITIS;
DERMATOLOGY;
DERMATOMYOSITIS;
DIARRHEA;
DISCOID LUPUS ERYTHEMATOSUS;
DIZZINESS;
DOSE TIME EFFECT RELATION;
DROWSINESS;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG TOLERANCE;
DRUG WITHDRAWAL;
DYSESTHESIA;
EOSINOPHILIC FASCIITIS;
EPIDERMOLYSIS BULLOSA HEREDITARIA;
EPILEPTIC STATE;
ERYTHEMA NODOSUM;
FATIGUE;
GLUCOSE TOLERANCE;
GRANULOMA ANNULARE;
HAIR LOSS;
HEADACHE;
HEARING LOSS;
HEART ARREST;
HEART ARRHYTHMIA;
HEMOLYSIS;
HUMAN;
HYPERPIGMENTATION;
IMMUNOMODULATION;
INSOMNIA;
LEUKOPENIA;
LICHEN PLANUS;
LICHEN SCLEROSUS ET ATROPHICUS;
LICHENOID ERUPTION;
LIGHT ABSORPTION;
LUNG EMBOLISM;
LUPUS ERYTHEMATOSUS;
LYMPHOCYTIC INFILTRATION;
MAXIMUM ALLOWABLE CONCENTRATION;
MAXIMUM PLASMA CONCENTRATION;
MAXIMUM TOLERATED DOSE;
METHEMOGLOBINEMIA;
MORPHEA;
MYOPATHY;
NAUSEA;
NECROBIOSIS LIPOIDICA;
NEUROMUSCULAR DISEASE;
PANCYTOPENIA;
PANNICULITIS;
PARESTHESIA;
PHOTODERMATOSIS;
PIGMENT DISORDER;
PORPHYRIA;
PORPHYRIA CUTANEA TARDA;
PRURITUS;
PSORIASIS;
PSYCHOSIS;
RASH;
RESTLESSNESS;
RETINOPATHY;
REVIEW;
RHEUMATOID ARTHRITIS;
SARCOIDOSIS;
SIDE EFFECT;
SINGLE DRUG DOSE;
SJOEGREN SYNDROME;
SKIN ALLERGY;
SKIN ATROPHY;
SKIN DISCOLORATION;
SKIN LUPUS ERYTHEMATOSUS;
SLEEP DISORDER;
SMOKING;
SOLAR URTICARIA;
STOMATITIS;
SYSTEMIC LUPUS ERYTHEMATOSUS;
T WAVE;
THROMBOCYTE AGGREGATION;
THROMBOCYTOPENIA;
TINNITUS;
TREATMENT RESPONSE;
VASCULITIS;
|
EID: 77957560307
PISSN: 16100379
EISSN: 16100387
Source Type: Journal
DOI: 10.1111/j.1610-0387.2010.07490.x Document Type: Review |
Times cited : (59)
|
References (21)
|